CoChat

Promotion of Both Proliferation and Neuronal Differentiation in Pluripotent P19 Cells with Stable Overexpression of the Glutamine Transporter slc38a1

Open access

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.

Abstract

BACKGROUND: We previously demonstrated the functional expression in newborn rat neocortical astrocytes of glutamine transporter (GlnT = slc38a1) believed to predominate in neurons over astroglia in the brain. In order to evaluate the possible role of this transporter in neurogenesis, we attempted to establish stable transfectants of GlnT in mouse embryonal carcinoma P19 cells endowed to proliferate for self-renewal and differentiate into progeny cells such as neurons and astroglia, in addition to in vitro pharmacological profiling of the green tea ingredient theanine, which is shown to be a potent inhibitor of glutamine transport mediated by GlnT in cultured neurons and astroglia. METHODOLOGY/PRINCIPAL FINDINGS: The full-length coding region of rat GlnT was inserted into a vector for gene transfection along with selection by G418, followed by culture with all-trans retinoic acid under floating conditions and subsequent dispersion for spontaneous differentiation under adherent conditions. Stable overexpression of GlnT led to marked increases in the size of round spheres formed during the culture for 4 days and 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide reduction, with concomitant promotion of subsequent differentiation into cells immunoreactive for a neuronal marker protein. In these stable GlnT transfectants before differentiation, drastic upregulation was seen for mRNA expression of several proneural genes with a basic helix-loop-helix domain such as NeuroD1. Although a drastic increase was seen in NeuroD1 promoter activity in stable GlnT transfectants, theanine doubled NeuroD1 promoter activity in stable transfectants of empty vector (EV), without affecting the promoter activity already elevated in GlnT transfectants. Similarly, theanine promoted cellular proliferation and neuronal differentiation in stable EV transfectants, but failed to further stimulate the acceleration of both proliferation and neuronal differentiation found in stable GlnT transfectants. CONCLUSIONS/SIGNIFICANCE: GlnT would promote both proliferation and neuronal differentiation through a mechanism relevant to the upregulation of particular proneural genes in undifferentiated P19 cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0048270

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Establishment of stable GlnT transfectants in pluripotent P19 cells. (A) P19 cells were stably transfected with GlnT expression vector, followed by selection of adequate clones after culture with G418 and subsequent determination of GlnT mRNA by Northern blotting. (B) Both EV2 and G13 clones were homogenized and subjected to determination of endogenous levels of Gln by HPLC. (C) Endogenous levels of Gln were quantified by HPLC in EV2, G13 and G17 clones (n = 8). *P<0.05, **P<0.01, significantly different from the control value in EV2 cells.
Figure 1 Establishment of stable GlnT transfectants in pluripotent P19 cells. (A) P19 cells were stably transfected with GlnT expression vector, followed by selection of adequate clones after culture with G418 and subsequent determination of GlnT mRNA by Northern blotting. (B) Both EV2 and G13 clones were homogenized and subjected to determination of endogenous levels of Gln by HPLC. (C) Endogenous levels of Gln were quantified by HPLC in EV2, G13 and G17 clones (n = 8). *P<0.05, **P<0.01, significantly different from the control value in EV2 cells.CC BY · PubMed Central
Figure 2 Proliferation of stable transfectants. (A) EV2, G13 and G17 clones were cultured with ATRA under floating conditions for 4 days. Typical phase contrast pictures are shown in this panel. (B) Transfectant clones were cultured with ATRA under floating conditions for a period up to 4 days, followed by calculation of the size of spheres formed on Day 2 and Day 4 in five different visual fields chosen at random in a blinded fashion (n = 3). (C) Cells were cultured for 4 days, followed by determination of MTT reduction (n = 8). *P<0.05, **P<0.01, significantly different from each control value in EV2 cells.
Figure 2 Proliferation of stable transfectants. (A) EV2, G13 and G17 clones were cultured with ATRA under floating conditions for 4 days. Typical phase contrast pictures are shown in this panel. (B) Transfectant clones were cultured with ATRA under floating conditions for a period up to 4 days, followed by calculation of the size of spheres formed on Day 2 and Day 4 in five different visual fields chosen at random in a blinded fashion (n = 3). (C) Cells were cultured for 4 days, followed by determination of MTT reduction (n = 8). *P<0.05, **P<0.01, significantly different from each control value in EV2 cells.CC BY · PubMed Central
Figure 3 Differentiation of stable transfectants. Cells were dispersed after the culture with ATRA for 4 days, followed by further culture for an additional 2 days and subsequent immunocytochemical detection of MAP2 together with Hoechst33342 staining (n = 8–9). Typical pictures are shown in the panel (A), while quantitative data are shown in the panel (B) for cells cultured for 5 and 6 days in total. Transfectant clones were also cultured with ATRA for 4 days, followed by dispersion for further culture for an additional 2 days and subsequent immunoblotting analysis on MAP2 (n = 4–6). Typical pictures are shown in the panel (C), while quantitative data are shown in the panel (D). *P<0.05, **P<0.01, significantly different from each control value in EV2 cells.
Figure 3 Differentiation of stable transfectants. Cells were dispersed after the culture with ATRA for 4 days, followed by further culture for an additional 2 days and subsequent immunocytochemical detection of MAP2 together with Hoechst33342 staining (n = 8–9). Typical pictures are shown in the panel (A), while quantitative data are shown in the panel (B) for cells cultured for 5 and 6 days in total. Transfectant clones were also cultured with ATRA for 4 days, followed by dispersion for further culture for an additional 2 days and subsequent immunoblotting analysis on MAP2 (n = 4–6). Typical pictures are shown in the panel (C), while quantitative data are shown in the panel (D). *P<0.05, **P<0.01, significantly different from each control value in EV2 cells.CC BY · PubMed Central
Figure 4 Proneural genes with bHLH in stable transfectants. Transfectants were cultured with ATRA for 4 days under floating conditions, followed by cell harvest for total RNA extraction and subsequent RT-PCR analysis (n = 3). Typical pictures are shown in the panel (A), while quantitative data are shown in the panel (B). Values represent percentages of the ratios of expression of a proneural gene to GAPDH in each stable transfectant over those in G17 transfectant cells. *P<0.05, **P<0.01, significantly different from each control value in EV2 cells. ND, not detectable.
Figure 4 Proneural genes with bHLH in stable transfectants. Transfectants were cultured with ATRA for 4 days under floating conditions, followed by cell harvest for total RNA extraction and subsequent RT-PCR analysis (n = 3). Typical pictures are shown in the panel (A), while quantitative data are shown in the panel (B). Values represent percentages of the ratios of expression of a proneural gene to GAPDH in each stable transfectant over those in G17 transfectant cells. *P<0.05, **P<0.01, significantly different from each control value in EV2 cells. ND, not detectable.CC BY · PubMed Central
Figure 5 Effects of theanine on NeuroD1 promoter activity in stable transfectants. (A) Each transfectant clone was transfected with NeuroD1 reporter plasmids with different lengths, followed by further culture with ATRA for an additional 4 days and subsequent determination of luciferase activity (n = 3). (B) Chemical structures of L-glutamine and L-theanine. (C) Each transfectant clone was also transfected with full-length NeuroD1 reporter plasmid, followed by further culture with ATRA in either the presence or absence of 100 µM theanine for an additional 4 days and subsequent determination of luciferase activity (n = 6). *P<0.05, **P<0.01, significantly different from each control value obtained in EV2 cells not cultured with theanine.
Figure 5 Effects of theanine on NeuroD1 promoter activity in stable transfectants. (A) Each transfectant clone was transfected with NeuroD1 reporter plasmids with different lengths, followed by further culture with ATRA for an additional 4 days and subsequent determination of luciferase activity (n = 3). (B) Chemical structures of L-glutamine and L-theanine. (C) Each transfectant clone was also transfected with full-length NeuroD1 reporter plasmid, followed by further culture with ATRA in either the presence or absence of 100 µM theanine for an additional 4 days and subsequent determination of luciferase activity (n = 6). *P<0.05, **P<0.01, significantly different from each control value obtained in EV2 cells not cultured with theanine.CC BY · PubMed Central
Figure 6 Effects of theanine on cellular proliferation and differentiation in stable transfectants. Each transfectant clone was cultured with ATRA for 4 days in either the presence or absence of 100 µM theanine. Typical phase contrast micrographs are shown in the panel (A), while quantitative data are shown for the size of spheres formed during culture (n = 20) in the panel (B) and for MTT reduction (n = 8) in the panel (C), respectively. (D) Each transfectant clone was also cultured with ATRA in either the presence or absence of 100 µM theanine for 4 days, followed by dispersion for further culture for an additional 2 days and subsequent quantitative determination of the ratio of MAP2-positive cells over Hoechst33342-positive cells (n = 4). **P<0.01, significantly different from each control value obtained in EV2 cells not cultured with theanine.
Figure 6 Effects of theanine on cellular proliferation and differentiation in stable transfectants. Each transfectant clone was cultured with ATRA for 4 days in either the presence or absence of 100 µM theanine. Typical phase contrast micrographs are shown in the panel (A), while quantitative data are shown for the size of spheres formed during culture (n = 20) in the panel (B) and for MTT reduction (n = 8) in the panel (C), respectively. (D) Each transfectant clone was also cultured with ATRA in either the presence or absence of 100 µM theanine for 4 days, followed by dispersion for further culture for an additional 2 days and subsequent quantitative determination of the ratio of MAP2-positive cells over Hoechst33342-positive cells (n = 4). **P<0.01, significantly different from each control value obtained in EV2 cells not cultured with theanine.CC BY · PubMed Central
Figure 7 Similarity between GlnT overexpression and theanine. P19 cells were cultured with ATRA for 3 or 4 days in either the presence or absence of theanine at a concentration range of 1 to 100 µM, followed by determination of cellular proliferation activity with (A) aggregate size (n = 4–5) and (B) MTT reduction (n = 4). (C) EV2 clone was cultured with ATRA for 4 days, followed by RNA extraction and subsequent determination of NeuroD1 mRNA expression (n = 4). **P<0.01, significantly different from each control value obtained in cells not exposed to theanine.
Figure 7 Similarity between GlnT overexpression and theanine. P19 cells were cultured with ATRA for 3 or 4 days in either the presence or absence of theanine at a concentration range of 1 to 100 µM, followed by determination of cellular proliferation activity with (A) aggregate size (n = 4–5) and (B) MTT reduction (n = 4). (C) EV2 clone was cultured with ATRA for 4 days, followed by RNA extraction and subsequent determination of NeuroD1 mRNA expression (n = 4). **P<0.01, significantly different from each control value obtained in cells not exposed to theanine.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 54 references

Cited by

See all 28

Metadata

Authors
Ogura, M., Kakuda, T., Takarada, T., Nakamichi, N., Fukumori, R., Kim, Y.-H., Hinoi, E., & Yoneda, Y.
Affiliations
Kanazawa University (JP)
Corresponding author
Yoneda, Yukio
Venue
PLoS ONE
Published
2012-10-24
Volume
7
Issue
10
Pages
e48270
ISSN
1932-6203 (ISSN-L)
OpenAlex
W1972801561
Cited by
28
References
54
Citations by year
2025: 3 · 2024: 2 · 2021: 2 · 2020: 2 · 2019: 5 · 2018: 1 · 2017: 2 · 2016: 2 · 2015: 4 · 2014: 3 · 2013: 2
FWCI
0.97
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Ministry of Education, Culture, Sports, Science and Technology (24650196, 22500330, No. 22500330)
  • Japan Society for the Promotion of Science (22590081, 22500330, 24650196)
Topics
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
Keywords
glutamine transporter, SLC38A1, P19 cells, neuronal differentiation, cell proliferation, neurogenesis, theanine, NeuroD1, proneural genes, bHLH transcription factors, astrocytes, embryonal carcinoma cells
MeSH terms
Animals, Cell Differentiation, Chromatography, High Pressure Liquid, Immunohistochemistry, Blotting, Northern, Reverse Transcriptase Polymerase Chain Reaction, Amino Acid Transport System A, Cell Line, Tumor, Cell Proliferation, Mice, Embryonal Carcinoma Stem Cells, Neurogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Promotion of Both Proliferation and Neuronal Differentiation in Pluripotent P19 Cells with Stable Overexpression of the Glutamine Transporter slc38a1. https://app.cochat.ai/papers/10.1371/journal.pone.0048270
The paper
Ogura, M., Kakuda, T., Takarada, T., Nakamichi, N., Fukumori, R., Kim, Y.-H., Hinoi, E., & Yoneda, Y. (2012). Promotion of Both Proliferation and Neuronal Differentiation in Pluripotent P19 Cells with Stable Overexpression of the Glutamine Transporter slc38a1. PLoS ONE. https://doi.org/10.1371/journal.pone.0048270

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.